Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Endocannabinoid regulation of β-cell functions: implications for glycaemic control and diabetes.

Diabetes, obesity & metabolism·2016

Same author

[Simmond's cachexia].

Journal de medecine et de chirurgie pratiques·2014

Same author

The European ethical review committee.

The International journal of risk & safety in medicine·2013

Same author

Microarterial anastomoses using the diode laser: long term morphological results.

Journal of biomedical optics·2012

Same author

Alexander Gordon (1752-99) and his writing: insights into medical thinking in the late eighteenth century.

The journal of the Royal College of Physicians of Edinburgh·2012

Same author

Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity.

Molecular psychiatry·2012

Search research articles

Related Experiment Video

Updated: Jul 22, 2026

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures

Published on: March 28, 2017

Caffeine as a metabolic probe: NAT2 phenotyping

L J Notarianni¹, P Dobrocky, G Godlewski

¹School of Pharmacy and Pharmacology, University of Bath.

British Journal of Clinical Pharmacology

|March 1, 1996

Summary

Caffeine

Area of Science:

Pharmacogenetics
Drug Metabolism
Biomarker Analysis

Background:

N-acetyltransferase type 2 (NAT2) status is typically determined using probe substances.
Caffeine has been utilized for over 15 years to assess acetylator phenotype.
Methodological challenges exist in interpreting caffeine's metabolic ratios for phenotype determination.

Purpose of the Study:

To evaluate the reliability of caffeine as a probe for N-acetyltransferase type 2 (NAT2) phenotyping.
To compare caffeine's metabolic ratios from spot and overnight urine samples with sulphadimidine phenotyping.
To identify potential theoretical and methodological issues in using caffeine for acetylator phenotyping.

Main Methods:

Assessed NAT2 status in 23 healthy young subjects.

More Related Videos

Metabolic Analysis of Drosophila melanogaster Larval and Adult Brains

Metabolic Analysis of Drosophila melanogaster Larval and Adult Brains

Published on: August 7, 2018

Caffeine Extraction, Enzymatic Activity and Gene Expression of Caffeine Synthase from Plant Cell Suspensions

Caffeine Extraction, Enzymatic Activity and Gene Expression of Caffeine Synthase from Plant Cell Suspensions

Published on: October 2, 2018

Related Experiment Videos

Last Updated: Jul 22, 2026

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures

Published on: March 28, 2017

Metabolic Analysis of Drosophila melanogaster Larval and Adult Brains

Metabolic Analysis of Drosophila melanogaster Larval and Adult Brains

Published on: August 7, 2018

Caffeine Extraction, Enzymatic Activity and Gene Expression of Caffeine Synthase from Plant Cell Suspensions

Caffeine Extraction, Enzymatic Activity and Gene Expression of Caffeine Synthase from Plant Cell Suspensions

Published on: October 2, 2018

Utilized both overnight and spot urine samples for caffeine metabolite analysis.

Employed sulphadimidine as a reference probe for acetylator phenotyping.

Performed frequency distribution analysis and Spearman's rank correlation.

Main Results:

Frequency distribution analysis revealed two distinct groups for sulphadimidine and spot caffeine samples, but not overnight caffeine samples.
Spearman's rank correlation values were low, indicating discrepancies between sulphadimidine and spot caffeine data.
Correlation between overnight and spot caffeine urine samples was poor.
Complex caffeine metabolism presents challenges for accurate phenotyping.

Conclusions:

The use of caffeine as a probe for acetylator phenotype is questionable due to methodological issues.
Caffeine's complex metabolism and variability in urine collection impact its reliability.
Further research is needed to understand variables affecting caffeine metabolism before its use as a reliable phenotype probe.